LINZAGOLIX
UNII 7CDW97HUEX

Substance Identification & Data

This profile provides standardized clinical and technical data for Linzagolix, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7CDW97HUEX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 935283-04-8 and the RxNorm Concept ID (RxCUI) 2621019. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

7CDW97HUEX

CAS Registry Number

935283-04-8

RxNorm Concept ID

2621019

Detailed Substance Profile

Preferred Name

LINZAGOLIX

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

7CDW97HUEX

The specific atomic composition represented as a molecular structure string.

InChIKey

C22H15F3N2O7S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

BMAAMIIYNNPHAB-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C148479

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

16656889

Unique identification number in the NCBI database of chemical substances.

INN ID

10711

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-52

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O=c1n(-c2c(F)cc(OC)c(OCc3c(F)c(F)ccc3OC)c2)c(=O)[nH]c4csc(C(=O)O)c41

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Linzagolix. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.